Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Avanos Medical (AVNS) stocks in Canada

Learn how to easily invest in Avanos Medical stocks.

Avanos Medical is a medical devices business based in the US. Avanos Medical stocks (AVNS.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $36.31 – a decrease of 1.65% over the previous week. Avanos Medical employs 5,380 staff and has a trailing 12-month revenue of around $736.2 million.

How to buy shares in Avanos Medical

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AVNS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Is it a good time to buy Avanos Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

How has Coronavirus impacted Avanos Medical's stock price?

Since the stock market crash in March caused by coronavirus, Avanos Medical's stock price has had significant positive movement.

Its last market close was $31.66, which is 2.91% up on its pre-crash value of $30.74 and 62.69% up on the lowest point reached during the March crash when the stocks fell as low as $19.46.

If you had bought $1,000 worth of Avanos Medical stocks at the start of February 2020, those stocks would have been worth $750.47 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,151.16.

Avanos Medical stock price (NYSE:AVNS)

Use our graph to track the performance of AVNS stocks over time.

Avanos Medical shares at a glance

Information last updated 2022-01-17.
Latest market close$31.66
52-week range$28.95 - $53.61
50-day moving average $32.70
200-day moving average $35.70
Wall St. target price$40.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.09

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Avanos Medical price performance over time

Historical closes compared with the close of $31.66 from 2022-01-18

1 week (2022-01-11) -3.21%
1 month (2021-12-17) 0.38%
3 months (2021-10-15) N/A
6 months (2021-07-19) -6.52%
1 year (2021-01-19) -32.70%
2 years (2020-01-17) -4.47%
3 years (2019-01-18) 45.23
5 years (2017-01-19) 37.38

Is Avanos Medical under- or over-valued?

Valuing Avanos Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avanos Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Avanos Medical's EBITDA

Avanos Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $58.1 million.

The EBITDA is a measure of a Avanos Medical's overall financial performance and is widely used to measure a its profitability.

Avanos Medical financials

Revenue TTM $736.2 million
Operating margin TTM 2.51%
Gross profit TTM $390.6 million
Return on assets TTM 0.68%
Return on equity TTM -4.07%
Profit margin -7.06%
Book value $26.24
Market capitalisation $1.6 billion

TTM: trailing 12 months

Avanos Medical share dividends

We're not expecting Avanos Medical to pay a dividend over the next 12 months.

Avanos Medical share price volatility

Over the last 12 months, Avanos Medical's shares have ranged in value from as little as $28.95 up to $53.61. A popular way to gauge a stock's volatility is its "beta".

AVNS.US volatility(beta: 0.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Avanos Medical's is 0.8829. This would suggest that Avanos Medical's shares are less volatile than average (for this exchange).

Avanos Medical overview

Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site